Literature DB >> 9877528

CADASIL syndrome: a genetic form of vascular dementia.

S Salloway1, J Hong.   

Abstract

Mental disorders due to cerebral microvascular disease have been known for over 100 years. Recently, an autosomal dominant form of cerebral arteriopathy (CADASIL) has been described in association with a Notch3 family gene on the short arm of chromosome 19. CADASIL causes subcortical lacunar infarction and dementia in over 80% of cases and depression in a large proportion of patients. Clinically, CADASIL may appear to be very similar to hypertensive microvascular disease (Binswanger's disease), a condition that is seen in the elderly. This article reviews the clinical, pathologic, and genetic features of CADASIL. CADASIL is of interest to neurologists and psychiatrists because it is the first syndrome of vascular dementia and depression with an identified gene. How the gene causes the widespread arteriopathy is not yet known. Insights gained from the study of CADASIL should help us better understand its etiology, as well as the options for treatment of the more common forms of microvascular disease seen in the elderly.

Entities:  

Mesh:

Year:  1998        PMID: 9877528     DOI: 10.1177/089198879801100205

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  3 in total

Review 1.  The neuropsychiatry of subcortical ischemic brain disease.

Authors:  D Feil; A Kumar
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

2.  Notch3 establishes brain vascular integrity by regulating pericyte number.

Authors:  Yuying Wang; Luyuan Pan; Cecilia B Moens; Bruce Appel
Journal:  Development       Date:  2013-12-04       Impact factor: 6.868

Review 3.  Genetic architecture of common non-Alzheimer's disease dementias.

Authors:  Rita Guerreiro; Elizabeth Gibbons; Miguel Tábuas-Pereira; Celia Kun-Rodrigues; Gustavo C Santo; Jose Bras
Journal:  Neurobiol Dis       Date:  2020-05-19       Impact factor: 5.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.